We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
-1.92%
1 Year Est. Return
+31.21%
3 Year Est. Return
+54.52%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.37%
AUM
$4.39B
AUM Growth
+$91.3M
Cap. Flow
-$806M
Cap. Flow %
-18.36%
Top 10 Hldgs %
17.15%
Holding
751
New
52
Increased
148
Reduced
80
Closed
39
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZCARW
601
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
0
RDBXW
602
DELISTED
Redbox Entertainment Inc. Warrant
RDBXW
0
IFIN.WS
603
DELISTED
InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share
IFIN.WS
0
IVCAW
604
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
0
VGASW icon
605
Verde Clean Fuels Warrant
VGASW
$628K
0
NCACW
606
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
0
ATAKR
607
DELISTED
Aurora Technology Acquisition Corp. Rights
ATAKR
$49K ﹤0.01%
+441,267
New +$47K
JSPRW icon
608
Japer Therapeutics Warrants
JSPRW
$180K
0
HLGN
609
DELISTED
Heliogen, Inc.
HLGN
$48K ﹤0.01%
649
+539
+490% +$70.1K
FAASW
610
DELISTED
DigiAsia Corp Warrant
FAASW
0
CITEW
611
DELISTED
Cartica Acquisition Corp Warrant
CITEW
0
CSLMW
612
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
0
LGVCW
613
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
0
SPCMW
614
DELISTED
Sound Point Acquisition Corp I, Ltd Warrant
SPCMW
0
LEAP.WS
615
DELISTED
Ribbit LEAP, Ltd. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exer
LEAP.WS
0
SANBW
616
DELISTED
Sanaby Health Acquisition Corp. I Warrant
SANBW
0
SST icon
617
System1
SST
$13.8M
$42K ﹤0.01%
+603
New +$76K
RCACW
618
DELISTED
Revelstone Capital Acquisition Corp. Warrant
RCACW
0
CHAA.WS
619
DELISTED
Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHAA.WS
0
BCSAW
620
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
0
NVACR
621
DELISTED
NorthView Acquisition Corporation Rights
NVACR
$40K ﹤0.01%
338,859
CLINR
622
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$38K ﹤0.01%
+198,763
New +$35.6K
FRBNW
623
DELISTED
Forbion European Acquisition Corp. Warrants
FRBNW
0
ASAQ.WS
624
DELISTED
Atlantic Avenue Acquisition Corp Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ASAQ.WS
0
BLEUR
625
DELISTED
bleuacacia ltd Rights
BLEUR
$35K ﹤0.01%
307,813

Similar funds

Highbridge Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Highbridge Capital Management held 751 positions worth $4.39B, up 2.1% from $4.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Highbridge Capital Management withdrew a net $806M in Q2 2022, closing 39 positions and reducing 80 holdings. Its most notable exit was KKR & Co, an estimated $37.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 40% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Highbridge Capital Management opened a new position in Jaguar Global Growth Corporation I Class A Ordinary Shares worth $17.8M.

  • Highbridge Capital Management's largest Q2 2022 buy was Jaguar Global Growth Corporation I Class A Ordinary Shares: 1,792,323 shares worth $17.8M.
  • Highbridge Capital Management added most to Pershing Square Tontine Holdings, Ltd. in Q2 2022, an estimated $38.9M increase.
  • Highbridge Capital Management's biggest Q2 2022 reduction was Paramount Global Class B, cutting an estimated $10.8M.
  • Highbridge Capital Management fully exited KKR & Co in Q2 2022, selling an estimated $37.4M.
  • Highbridge Capital Management's ten largest holdings make up 17% of its $4.39B portfolio in Q2 2022.
  • Highbridge Capital Management opened 52 new positions and closed 39 in Q2 2022.
  • Highbridge Capital Management's portfolio value rose 2.1% quarter-over-quarter to $4.39B.

Based on Highbridge Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.